In patient without spleens or with poorly functioning ones does a newly licensed paediatric pneumococcal conjugate vaccine assist with preventing pneumococcal sepsis in preventing deaths or severe impairments (which are very costly) from overwhelming post splenectomy sepsis

Trial Profile

In patient without spleens or with poorly functioning ones does a newly licensed paediatric pneumococcal conjugate vaccine assist with preventing pneumococcal sepsis in preventing deaths or severe impairments (which are very costly) from overwhelming post splenectomy sepsis

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Jun 2016

At a glance

  • Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal vaccine
  • Indications Pneumococcal infections
  • Focus Pharmacodynamics
  • Acronyms PAPI
  • Most Recent Events

    • 08 Jun 2016 Status changed from recruiting to completed.
    • 16 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top